Lowest-Rated StocksLowest-RatedNASDAQ:DOCS Doximity (DOCS) Stock Forecast, Price & News $20.16 +0.27 (+1.36%) (As of 09/25/2023 ET) Add Compare Share Share Today's Range$19.71▼$20.3850-Day Range$19.89▼$35.8352-Week Range$19.71▼$40.12Volume3.11 million shsAverage Volume1.96 million shsMarket Capitalization$3.93 billionP/E Ratio36.66Dividend YieldN/APrice Target$29.50 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Doximity MarketRank™ ForecastAnalyst RatingHold2.00 Rating ScoreUpside/Downside46.3% Upside$29.50 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews Sentiment0.14Based on 3 Articles This WeekInsider TradingSelling Shares$786,781 Sold Last QuarterProj. Earnings Growth18.33%From $0.60 to $0.71 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.92 out of 5 starsMedical Sector53rd out of 961 stocksCustom Computer Programming Services Industry2nd out of 24 stocks 4.0 Analyst's Opinion Consensus RatingDoximity has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 2 buy ratings, 6 hold ratings, and 2 sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $29.50, Doximity has a forecasted upside of 46.3% from its current price of $20.16.Amount of Analyst CoverageDoximity has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for DOCS. Previous Next 0.0 Dividend Strength Dividend YieldDoximity does not currently pay a dividend.Dividend GrowthDoximity does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DOCS. Previous Next 1.7 News and Social Media Coverage News SentimentDoximity has a news sentiment score of 0.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.51 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Doximity this week, compared to 3 articles on an average week.Search InterestOnly 14 people have searched for DOCS on MarketBeat in the last 30 days. This is a decrease of -30% compared to the previous 30 days.MarketBeat Follows5 people have added Doximity to their MarketBeat watchlist in the last 30 days. This is an increase of 25% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Doximity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $786,781.00 in company stock.Percentage Held by Insiders39.40% of the stock of Doximity is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions54.65% of the stock of Doximity is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Doximity are expected to grow by 18.33% in the coming year, from $0.60 to $0.71 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Doximity is 36.66, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 122.24.Price to Earnings Ratio vs. SectorThe P/E ratio of Doximity is 36.66, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 140.37.Price to Earnings Growth RatioDoximity has a PEG Ratio of 3.22. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDoximity has a P/B Ratio of 4.05. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Doximity (NASDAQ:DOCS) StockDoximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.Read More DOCS Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DOCS Stock News HeadlinesSeptember 19, 2023 | americanbankingnews.comReviewing Amdocs (NASDAQ:DOX) & Doximity (NASDAQ:DOCS)September 6, 2023 | finance.yahoo.comImplied Volatility Surging for Doximity (DOCS) Stock OptionsSeptember 25, 2023 | Behind the Markets (Ad)The single greatest medical breakthrough of all time?We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.September 6, 2023 | markets.businessinsider.comMorgan Stanley Keeps Their Sell Rating on Doximity (DOCS)September 5, 2023 | markets.businessinsider.comWhere Doximity Stands With AnalystsAugust 26, 2023 | prnewswire.comDoximity, Inc. Investigation Notice: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of Doximity, Inc. (NYSE: DOCS) InvestorsAugust 24, 2023 | msn.comDoximity: Rating Downgrade As Investors Shift Focus To The Near-Term OutlookAugust 23, 2023 | benzinga.comROSEN, TRUSTED INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Inquire About Securities Class Action Investigation – DOCSSeptember 25, 2023 | Legacy Research (Ad)Watch SHOCKING Footage of AI Facility with Ties to Elon MuskI recently traveled more than 3,000 miles and shot this video outside what could end up being Elon Musk’s biggest secret. Most people don’t know about this facility, but it could be the most important AI project in the world. What’s happening inside these walls is so important that our government has declared it a matter of national security.August 18, 2023 | benzinga.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCSAugust 16, 2023 | finance.yahoo.com1 Growth Stock Down Nearly 40% to Buy and Hold For 10 YearsAugust 11, 2023 | markets.businessinsider.comRobert W. Baird Reaffirms Their Buy Rating on Doximity (DOCS)August 11, 2023 | msn.comWells Fargo Maintains Doximity Inc - (DOCS) Equal-Weight RecommendationAugust 11, 2023 | seekingalpha.comDoximity, Inc. 2024 Q1 - Results - Earnings Call PresentationAugust 11, 2023 | msn.comDoximity Stock Plunges After Cut to Forecast. Analysts Are Concerned.August 10, 2023 | msn.comRaymond James Maintains Doximity Inc - (DOCS) Outperform RecommendationAugust 9, 2023 | benzinga.comDOCS Shareholder News: Johnson Fistel Encourages Doximity Shareholders with Losses to Contact the Firm Regarding InvestigationAugust 9, 2023 | benzinga.comWhy Doximity Stock Took A Nosedive TodayAugust 9, 2023 | msn.comWhy Shares of Doximity Are Falling WednesdayAugust 9, 2023 | markets.businessinsider.comPre-market Movers: TYGO, BRSH, TNGX, VERI, DOCS…August 9, 2023 | investing.comDoximity tumbles 28% after cutting full-year forecast; earns 2 downgradesAugust 9, 2023 | markets.businessinsider.comBank of America Securities Sticks to Its Sell Rating for Doximity (DOCS)August 9, 2023 | msn.comDoximity (NYSE: DOCS) Crashes after Lowered GuidanceAugust 9, 2023 | investorplace.comWhy Is Doximity (DOCS) Stock Down 23% Today?August 9, 2023 | seekingalpha.comDoximity Earnings: Too Many Problems, SellAugust 8, 2023 | theglobeandmail.comDoximity (DOCS) Reports Q1: Everything You Need To Know Ahead Of EarningsAugust 8, 2023 | finance.yahoo.comDoximity (DOCS) Surpasses Q1 Earnings and Revenue EstimatesSee More Headlines Receive DOCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Doximity and its competitors with MarketBeat's FREE daily newsletter. Email Address DOCS Company Calendar Last Earnings8/08/2023Today9/25/2023Next Earnings (Estimated)11/09/2023Fiscal Year End3/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Custom computer programming services Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:DOCS CUSIPN/A CIK1516513 Webwww.doximity.com Phone650-549-4330FaxN/AEmployees900Year FoundedN/APrice Target and Rating Average Stock Price Forecast$29.50 High Stock Price Forecast$45.00 Low Stock Price Forecast$21.00 Forecasted Upside/Downside+45.2%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)$0.55 Trailing P/E Ratio36.93 Forward P/E Ratio33.85 P/E Growth3.22Net Income$112.82 million Net Margins27.20% Pretax Margin33.23% Return on Equity13.11% Return on Assets11.25% Debt Debt-to-Equity RatioN/A Current Ratio7.46 Quick Ratio7.46 Sales & Book Value Annual Sales$419.05 million Price / Sales9.44 Cash Flow$0.73 per share Price / Cash Flow27.69 Book Value$4.98 per share Price / Book4.08Miscellaneous Outstanding Shares194,710,000Free Float117,995,000Market Cap$3.95 billion OptionableNot Optionable Beta1.02 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Jeffrey A. Tangney (Age 50)Co-Founder, CEO & Chairperson Comp: $243.73kDr. Nate Gross M.D. (Age 39)Co-Founder & Chief Strategy Officer Comp: $455.54kMs. Anna Bryson (Age 33)Chief Financial Officer Comp: $453.71kMs. Jennifer W. Chaloemtiarana (Age 55)Gen. Counsel & Corp. Sec. Comp: $504.04kMr. Paul Jorgensen (Age 52)Chief Revenue Officer Comp: $455.13kMs. Shari BuckCo-founder and SVP People & OpsMr. Jey BalachandranChief Technology OfficerMr. Perry Scott GoldHead of Investor RelationsJim RivasHead of Corp. CommunicationsMr. Bruno MirandaSr. VP of EngineeringMore ExecutivesKey CompetitorsMerit Medical SystemsNASDAQ:MMSIACADIA PharmaceuticalsNASDAQ:ACADImmunoGenNASDAQ:IMGNEvotecNASDAQ:EVOSurgery PartnersNASDAQ:SGRYView All CompetitorsInsiders & InstitutionsCraig OverpeckSold 1,000 sharesTotal: $21,480.00 ($21.48/share)Wolverine Trading LLCSold 8,400 shares on 8/23/2023Ownership: 0.000%Virginia Retirement Systems ET ALBought 28,200 shares on 8/22/2023Ownership: 0.014%Teachers Retirement System of The State of KentuckyBought 66,300 shares on 8/21/2023Ownership: 0.073%California State Teachers Retirement SystemBought 3,903 shares on 8/21/2023Ownership: 0.067%View All Insider TransactionsView All Institutional Transactions DOCS Stock - Frequently Asked Questions Should I buy or sell Doximity stock right now? 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Doximity in the last year. There are currently 2 sell ratings, 6 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" DOCS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DOCS, but not buy additional shares or sell existing shares. View DOCS analyst ratings or view top-rated stocks. What is Doximity's stock price forecast for 2023? 10 brokerages have issued twelve-month price targets for Doximity's shares. Their DOCS share price forecasts range from $21.00 to $45.00. On average, they predict the company's share price to reach $29.50 in the next year. This suggests a possible upside of 45.2% from the stock's current price. View analysts price targets for DOCS or view top-rated stocks among Wall Street analysts. How have DOCS shares performed in 2023? Doximity's stock was trading at $33.56 on January 1st, 2023. Since then, DOCS stock has decreased by 39.5% and is now trading at $20.31. View the best growth stocks for 2023 here. When is Doximity's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023. View our DOCS earnings forecast. How were Doximity's earnings last quarter? Doximity, Inc. (NASDAQ:DOCS) issued its earnings results on Tuesday, August, 8th. The company reported $0.14 earnings per share for the quarter, beating analysts' consensus estimates of $0.11 by $0.03. The firm earned $108.47 million during the quarter, compared to analyst estimates of $106.98 million. Doximity had a trailing twelve-month return on equity of 13.11% and a net margin of 27.20%. What ETFs hold Doximity's stock? ETFs with the largest weight of Doximity (NASDAQ:DOCS) stock in their portfolio include Jacob Forward ETF (JFWD), Global X Telemedicine & Digital Health ETF (EDOC), Fidelity Digital Health ETF (FDHT), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD), Syntax Stratified MidCap ETF (SMDY), Natixis U.S. Equity Opportunities ETF (EQOP) and BlackRock Future Innovators ETF (BFTR). What guidance has Doximity issued on next quarter's earnings? Doximity updated its second quarter 2024 earnings guidance on Tuesday, August, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $108.50 million-$109.50 million, compared to the consensus revenue estimate of $121.35 million. When did Doximity IPO? (DOCS) raised $501 million in an IPO on Thursday, June 24th 2021. The company issued 23,300,000 shares at $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities served as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers. What is Doximity's stock symbol? Doximity trades on the NASDAQ under the ticker symbol "DOCS." Who are Doximity's major shareholders? Doximity's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (5.49%), Clearbridge Investments LLC (3.45%), Baillie Gifford & Co. (3.39%), Eventide Asset Management LLC (2.00%), State Street Corp (1.63%) and Geode Capital Management LLC (1.08%). Insiders that own company stock include Anna Bryson, Craig Overpeck, Gilbert H Kliman, Interwest Partners X Lp, Joseph B Kleine, Kevin Spain, Kira Scherer Wampler, Paul W Jorgensen and Timothy S Cabral. View institutional ownership trends. How do I buy shares of Doximity? Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Doximity's stock price today? One share of DOCS stock can currently be purchased for approximately $20.31. How much money does Doximity make? Doximity (NASDAQ:DOCS) has a market capitalization of $3.95 billion and generates $419.05 million in revenue each year. The company earns $112.82 million in net income (profit) each year or $0.55 on an earnings per share basis. How many employees does Doximity have? The company employs 900 workers across the globe. How can I contact Doximity? The official website for the company is www.doximity.com. The company can be reached via phone at 650-549-4330 or via email at ir@doximity.com. This page (NASDAQ:DOCS) was last updated on 9/25/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Doximity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.